0,953  0,001  Melanin inhibitor
0,922  0,002  NOS2 expression inhibitor
0,916  0,003  Antihypercholesterolemic
0,915  0,003  Chemopreventive
0,866  0,002  Proliferative diseases treatment
0,855  0,003  Caspase 3 stimulant
0,859  0,009  Transcription factor NF kappa B inhibitor
0,850  0,005  Caspase 9 stimulant
0,854  0,010  Apoptosis agonist
0,807  0,002  Amylase inhibitor
0,777  0,005  Antioxidant
0,757  0,008  Antileukemic
0,754  0,009  Antidiabetic
0,754  0,009  Cyclophilin D inhibitor
0,762  0,021  Antiinflammatory
0,724  0,030  Alpha-glucosidase inhibitor
0,694  0,005  Hypoglycemic
0,692  0,004  Skin whitener
0,683  0,005  Cardioprotectant
0,678  0,006  Nitric oxide antagonist
0,677  0,010  Antibacterial
0,669  0,005  Antineoplastic (lymphoma)
0,670  0,012  Respiratory analeptic
0,663  0,005  Antipyretic
0,654  0,008  NOS3 expression inhibitor
0,669  0,024  Antineoplastic (breast cancer)
0,641  0,008  Hepatic disorders treatment
0,624  0,007  Vasodilator, coronary
0,629  0,012  5 Hydroxytryptamine release stimulant
0,618  0,008  Antineoplastic (glioma)
0,617  0,008  DNA damaging
0,609  0,004  Hepatoprotectant
0,625  0,021  Antineoplastic (colorectal cancer)
0,608  0,005  Genotoxic
0,610  0,008  Free radical scavenger
0,625  0,027  Antineoplastic (lung cancer)
0,603  0,005  Antineoplastic (glioblastoma multiforme)
0,600  0,010  Apoptosis antagonist
0,606  0,022  Antineoplastic (colon cancer)
0,595  0,012  Cytostatic
0,575  0,004  VCAM1 expression inhibitor
0,564  0,005  Topoisomerase II inhibitor
0,575  0,018  Antineoplastic (ovarian cancer)
0,563  0,006  Antihypoxic
0,567  0,012  Antineoplastic (brain cancer)
0,575  0,029  TNF expression inhibitor
0,548  0,006  Monophenol monooxygenase inhibitor
0,545  0,009  Vascular (periferal) disease treatment
0,553  0,017  Mutagenic
0,535  0,004  Neurotrophic factor enhancer
0,541  0,013  Antiprotozoal (Leishmania)
0,535  0,007  ICAM1 expression inhibitor
0,534  0,008  Antihypertriglyceridemic
0,538  0,019  Cytotoxic
0,521  0,015  Antiparasitic
0,501  0,001  Sodium/glucose cotransporter inhibitor
0,527  0,028  Prostate cancer treatment
0,523  0,027  Immunosuppressant
0,509  0,021  Analeptic
0,489  0,003  Carcinogenic, group 2A
0,506  0,021  Antifungal
0,499  0,024  Antineoplastic (melanoma)
0,479  0,005  NOS3 expression enhancer
0,482  0,011  Antimutagenic
0,472  0,004  Topoisomerase I inhibitor
0,506  0,039  CYP3A4 substrate
0,468  0,004  Antihemorrhagic
0,459  0,000  Sodium/glucose cotransporter 2 inhibitor
0,462  0,005  Protein kinase stimulant
0,479  0,023  Antiosteoporotic
0,466  0,014  Angiogenesis stimulant
0,476  0,030  CYP2C19 inhibitor
0,468  0,025  Chemoprotective
0,472  0,032  Bone diseases treatment
0,462  0,025  Sensitization
0,451  0,015  Antineoplastic (osteosarcoma)
0,442  0,020  Tumour necrosis factor alpha release inhibitor
0,457  0,039  Cholesterol antagonist
0,419  0,013  Antiviral (Herpes)
0,437  0,031  Radioprotector
0,418  0,016  Antineoplastic (lymphocytic leukemia)
0,440  0,040  Antithrombotic
0,411  0,015  Antineoplastic (sarcoma)
0,447  0,051  Histamine release inhibitor
0,462  0,073  Antineoplastic (solid tumors)
0,394  0,005  Carcinogenic, group 1
0,407  0,022  Antineoplastic (renal cancer)
0,400  0,016  Antihelmintic
0,403  0,021  DNA synthesis inhibitor
0,384  0,005  Aldose reductase substrate
0,404  0,026  Interleukin 2 agonist
0,398  0,024  Vasodilator
0,405  0,032  Carcinogenic
0,417  0,045  Immunostimulant
0,398  0,032  Antidiabetic (type 2)
0,387  0,022  UDP-glucuronosyltransferase substrate
0,374  0,014  Antiviral (Influenza)
0,373  0,013  Antineoplastic (squamous cell carcinoma)
0,386  0,034  Hypoxia-inducible factor 1 alpha inhibitor
0,366  0,016  Platelet adhesion inhibitor
0,389  0,042  Spasmolytic
0,354  0,008  Renal failure treatment
0,387  0,044  AR expression inhibitor
0,385  0,042  Lipoprotein disorders treatment
0,368  0,027  Antineoplastic (small cell lung cancer)
0,368  0,029  Antineoplastic (liver cancer)
0,346  0,007  Psychosexual dysfunction treatment
0,359  0,024  Cyclic AMP phosphodiesterase inhibitor
0,370  0,042  Antineoplastic (cervical cancer)
0,357  0,031  Antimitotic
0,384  0,061  Vasodilator, peripheral
0,323  0,002  Alpha-mannosidase inhibitor
0,324  0,006  Topoisomerase II alpha inhibitor
0,330  0,015  Lipid peroxidase inhibitor
0,319  0,005  Selectin antagonist
0,316  0,016  Protein-tyrosine phosphatase inhibitor
0,350  0,052  Teratogen
0,343  0,048  UGT1A9 substrate
0,301  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,340  0,051  Embryotoxic
0,317  0,028  UGT1A1 substrate
0,335  0,047  Antineoplastic (multiple myeloma)
0,309  0,022  Peptidyltransferase inhibitor
0,337  0,055  Antineoplastic (pancreatic cancer)
0,329  0,048  Antineoplastic (non-small cell lung cancer)
0,282  0,002  Mannosidase inhibitor
0,308  0,031  Sedative
0,328  0,051  UGT2B4 substrate
0,319  0,046  Antiamyloidogenic
0,265  0,005  DNA repair enzyme inhibitor
0,268  0,007  Cyclooxygenase 3 inhibitor
0,276  0,025  Antineoplastic (carcinoma)
0,255  0,005  Antiviral (Influenza B)
0,284  0,036  Antihypotensive
0,246  0,004  Neuraminidase inhibitor
0,282  0,040  Septic shock treatment
0,292  0,053  Myocardial infarction treatment
0,260  0,026  Nitric-oxide synthase stimulant
0,249  0,018  Antifungal enhancer
0,243  0,017  DNA intercalator
0,300  0,075  Antiischemic
0,247  0,027  Liver fibrosis treatment
0,234  0,018  Antitussive
0,220  0,004  Phosphodiesterase 6D inhibitor
0,213  0,007  Estrogen agonist
0,224  0,020  Alkylator
0,241  0,038  Antipruritic, non-allergic
0,256  0,056  Amyloid beta aggregation inhibitor
0,231  0,037  Diabetic nephropathy treatment
0,279  0,089  Antimycobacterial
0,297  0,108  Stroke treatment
0,324  0,136  Antiarthritic
0,219  0,032  Interleukin 6 antagonist
0,219  0,035  Interferon gamma antagonist
0,203  0,021  Antineoplastic antibiotic
0,200  0,020  Expectorant
0,184  0,005  Neuraminidase (influenza) inhibitor
0,181  0,002  Sodium/glucose cotransporter 1 inhibitor
0,186  0,009  Postmenopausal disorders treatment
0,179  0,005  Antibiotic Glycopeptide-like
0,212  0,038  Antiviral (Influenza A)
0,204  0,034  ATPase inhibitor
0,184  0,015  Beta glucuronidase inhibitor
0,206  0,040  Cystic fibrosis treatment
0,174  0,011  Toll-Like receptor 4 antagonist
0,233  0,075  Hypolipemic
0,178  0,022  UDP-glucose 4-epimerase inhibitor
0,237  0,082  Antidiabetic symptomatic
0,311  0,157  Alzheimer's disease treatment
0,159  0,006  Estrogen receptor beta agonist
0,180  0,029  Antifungal (Cryptococcus)
0,163  0,013  Transcription factor NF kappa B stimulant
0,282  0,136  Antiprotozoal
0,205  0,061  P-glycoprotein inhibitor
0,191  0,047  Antineoplastic (bone cancer)
0,186  0,043  Antidiarrheal
0,174  0,035  Antiviral (Hepatitis B)
0,217  0,078  RNA-directed DNA polymerase inhibitor
0,148  0,009  Histone deacetylase stimulant
0,148  0,009  Histone deacetylase SIRT1 stimulant
0,179  0,043  Mannose-6-phosphate isomerase inhibitor
0,163  0,032  Microtubule formation inhibitor
0,219  0,089  Platelet antagonist
0,152  0,023  Estrogen antagonist
0,271  0,143  Antipruritic, allergic
0,172  0,046  Cell wall synthesis inhibitor
0,133  0,013  ATPase (Vacuolar H+) inhibitor
0,242  0,123  CYP3A4 inhibitor
0,146  0,027  Dementia treatment
0,174  0,056  Acute respiratory distress syndrome (ARDS) treatment
0,151  0,034  Xanthine oxidase inhibitor
0,146  0,031  AMP-activated protein kinase stimulant
0,141  0,026  Vascular dementia treatment
0,125  0,014  Na+ K+ transporting ATPase inhibitor
0,147  0,037  Papain-like protease (SARS coronavirus) inhibitor
0,124  0,013  Antiviral (Dengue virus)
0,190  0,081  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,129  0,024  NADH dehydrogenase inhibitor
0,164  0,061  Insulin secretagoues
0,154  0,054  Cyclooxygenase 1 inhibitor
0,155  0,062  Hemostatic
0,105  0,013  Antitreponemal
0,120  0,027  Antibiotic
0,148  0,056  Alpha-N-acetylglucosaminidase inhibitor
0,144  0,052  DNA polymerase I inhibitor
0,124  0,038  CDC-like kinase 3 inhibitor
0,129  0,044  Alpha 2c adrenoreceptor antagonist
0,113  0,030  Restless leg syndrome treatment
0,118  0,035  Estrogen receptor beta antagonist
0,207  0,125  Renal disease treatment
0,109  0,029  Phosphofructokinase-1 inhibitor
0,134  0,055  Antineoplastic (uterine cancer)
0,083  0,004  Antibiotic Aminoglycoside-like
0,099  0,020  Phosphodiesterase VI inhibitor
0,238  0,160  CYP2C9 substrate
0,091  0,016  Protein 50S ribosomal subunit inhibitor
0,153  0,080  Thrombolytic
0,118  0,047  Sulfotransferase substrate
0,166  0,098  Anesthetic general
0,117  0,051  Electron transport complex I inhibitor
0,269  0,203  5 Hydroxytryptamine release inhibitor
0,119  0,055  Mucolytic
0,072  0,010  Heparanase inhibitor
0,234  0,173  Antiobesity
0,196  0,136  CYP2C19 substrate
0,064  0,005  Cholesterol absorption inhibitor
0,063  0,005  Protein 30S ribosomal subunit inhibitor
0,091  0,033  Lipase inhibitor
0,117  0,060  Cystathionine beta-synthase inhibitor
0,117  0,061  Photosensitizer
0,067  0,014  Glucose-6-phosphate isomerase inhibitor
0,076  0,025  Antimycoplasmal
0,104  0,054  Antineoplastic, alkylator
0,144  0,093  Prostatic (benign) hyperplasia treatment
0,098  0,050  Thioredoxin inhibitor
0,061  0,016  Factor III inhibitor
0,120  0,078  Acetylcholinesterase inhibitor
0,104  0,064  Antihypermotility
0,067  0,029  Aldose reductase inhibitor
0,092  0,057  Triose-phosphate isomerase inhibitor
0,062  0,027  Acetyl-CoA transferase 2 inhibitor
0,067  0,033  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,129  0,095  Antidote
0,084  0,051  Glycine receptor antagonist
0,129  0,097  Antidiabetic (type 1)
0,055  0,026  Equilibrative nucleoside transport protein inhibitor
0,185  0,158  CYP2D6 substrate
0,184  0,157  Radiosensitizer
0,110  0,085  Alcohol dehydrogenase substrate
0,099  0,074  Choleretic
0,083  0,059  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,119  0,096  Acaricide
0,104  0,082  Cell adhesion inhibitor
0,110  0,091  Tubulin antagonist
0,074  0,055  Carbonic anhydrase XIII inhibitor
0,038  0,022  Estrogen receptor alpha agonist
0,138  0,122  Wound healing agent
0,020  0,007  Telomerase stimulant
0,036  0,024  Ceramide glucosyltransferase inhibitor
0,101  0,089  Beta amyloid protein antagonist
0,060  0,049  Nitric oxide donor
0,048  0,037  Topoisomerase II beta inhibitor
0,148  0,138  Antiulcerative
0,026  0,016  Vanilloid 2 agonist
0,027  0,017  Toll-Like receptor 4 agonist
0,121  0,112  Restenosis treatment
0,079  0,071  T cell inhibitor
0,024  0,016  Adenosine A1 receptor agonist
0,096  0,088  Adenylate cyclase inhibitor
0,052  0,045  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,076  0,071  Antineoplastic alkaloid
0,048  0,043  Glucose-6-phosphate translocase inhibitor
0,022  0,018  Dopamine D1 agonist
0,122  0,120  Adenylate cyclase stimulant
0,082  0,081  Carcinogenic, group 2B

